Publications 2014
275.
Williams G, Al Moasseb Z, Walters M, Delles C, Mischak H, Mullen W, Dawson J.
Urinary Proteomics to Support Diagnosis in Cases of Suspected Stroke
Cerebrovascular Diseases 2014, 37(Supp1):679.
274.
Filip S, Zoidakis J, Vlahou A, Mischak H.
Advances in urinary proteome analysis and applications in systems biology
Bioanalysis. 2014, 6(19):2549-69.
273.
Seetho IW, Siwy J, Albalat A, Mullen W, Mischak H, Parker RJ, Craig S, Duffy N, Hardy KJ, Burniston JG, Wilding JP.
Urinary proteomics in obstructive sleep apnoea and obesity
Eur J Clin Invest. 2014, 44(11):1104-15.
272.
Nkuipou-Kenfack E, Koeck T, Mischak H, Pich A, Schanstra JP, Zürbig P, Schumacher B.
Proteome analysis in the assessment of ageing
Ageing Res Rev. 2014, 18C:74-85.
271.
Stalmach A, Johnsson H, McInnes IB, Husi H, Klein J, Dakna M, Mullen W, Mischak H, Porter D.
Identification of urinary Peptide biomarkers associated with rheumatoid arthritis
PLoS One. 2014, 9(8):e104625.
270.
Zhang Z, Staessen JA, Thijs L, Gu Y, Liu Y, Jacobs L, Koeck T, Zürbig P, Mischak H, Kuznetsova T.
Left ventricular diastolic function in relation to the urinary proteome: A proof-of-concept study in a general population
Int J Cardiol. 2014, 176(1):158-65. Epub 2014 Jul 12.
269.
Pejchinovski M, Mischak H, Chapman A, Kistler A.
A urine peptidome-based score accurately predicts the risk of reaching ESRD in ADPKD patients
Swiss Medical Weekly
2014, 144(Suppl 208):3S.
268.
Currie G, Friar M, Brown C, Flynn J, Mullen W, Mischak H, Delles C.
P3.5 Urinary Proteomics and Vascular Phenotyping in a Cohort of Type 2 Diabetic Patients at High Cardiovascular Risk
Artery Research
2014, 8(4):137.
267.
Gu YM, Thijs L, Liu YP, Zhang Z, Jacobs L, Koeck T, Zürbig P, Lichtinghagen R, Brand K, Kuznetsova T, Olivi L, Verhamme P, Delles C, Mischak H, Staessen JA.
The urinary proteome as correlate and predictor of renal function in a population study
Nephrol Dial Transplant. 2014, 29(12):2260-8. Epub 2014 Jun 30.
266.
Filip S, Pontillo C, Peter Schanstra J, Vlahou A, Mischak H, Klein J.
Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases
Expert Rev Proteomics. 2014, 11(5):535-48. Epub 2014 Jun 24.
265.
Koss MJ, Hoffmann J, Nguyen N, Pfister M, Mischak H, Mullen W, Husi H, Rejdak R, Koch F, Jankowski J, Krueger K, Bertelmann T, Klein J, Schanstra JP, Siwy J.
Proteomics of vitreous humor of patients with exudative age-related macular degeneration
PLoS One. 2014, 14;9(5):e96895.
264.
Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés A, Lundin U, Weinberger KM, Dakna M, Delles C, Mullen W, Husi H, Klein J, Koeck T, Zürbig P, Mischak H.
Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease
PLoS One. 2014, 9(5):e96955.
263.
Mullen W, Saigusa D, Abe T, Adamski J, Mischak H.
Proteomics and Metabolomics as Tools to Unravel Novel Culprits and Mechanisms of Uremic Toxicity: Instrument or Hype?
Semin Nephrol. 2014, 34(2):180-190. Epub 2014 Feb 18.
262.
Siwy J, Schanstra JP, Argiles A, Bakker SJ, Beige J, Boucek P, Brand K, Delles C, Duranton F, Fernandez-Fernandez B, Jankowski ML, Al Khatib M, Kunt T, Lajer M, Lichtinghagen R, Lindhardt M, Maahs DM, Mischak H, Mullen W, Navis G, Noutsou M, Ortiz A, Persson F, Petrie JR, Roob JM, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Snell-Bergeon J, Spasovski G, Stojceva-Taneva O, Trillini M, von der Leyen H, Winklhofer-Roob BM, Zürbig P, Jankowski J.
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy
Nephrol Dial Transplant. 2014, 29(8):1563-70. Epub 2014 Mar 2.
261.
Wisniacki N, Wei R, Gao B, Stebbins C, Dearth A, Ranger A, Mischak H, Siwy J, Petri M, Burkly L.
FRI0439 – Urinary Collagen Fragments Are Reduced in Lupus Nephritis Subjects with Renal Dysfunction
Annals of the Rheumatic Diseases 2014, 73(Suppl 2):546.
260.
Filippatos G, Farmakis DT, Gogas B, Mullen W, Nikolaou M, Parissis J, Anastasiou-Nana M, Mischak H.
P1311 - Urinary proteomics for the identification of disease-specific biomarkers in heart failure with reduced ejection fraction
European Heart Journal 2014, 35(Suppl1):227.
259.
Frantzi M, Bhat A, Latosinska A.
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
Clin Transl Med. 2014, 29;3(1):7.
258.
Husi H, Van Agtmael T, Mullen W, Bahlmann FH, Schanstra JP, Vlahou A, Delles C, Perco P, Mischak H.
Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease
Circ Cardiovasc Genet. 2014, 7(2):161-70. Epub 2014 Feb 26.
257.
Mischak H, Vlahou A, Righetti PG, Calvete JJ.
Putting value in biomarker research and reporting
J Proteomics. 2014, 96:A1-3.
256.
Albalat A, Husi H, Siwy J, Nally JE, McLauglin M, Eckersall PD, Mullen W.
Capillary electrophoresis interfaced with a mass spectrometer (CE-MS): technical considerations and applicability for biomarker studies in animals
Curr Protein Pept Sci. 2014, 15(1):23-35.
255.
Albalat A, Husi H, Stalmach A, Schanstra JP, Mischak H.
Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications
Bioanalysis. 2014, 6(2):247-66.
254.
Klein J, Buffin-Meyer B, Mullen W, Carty DM, Delles C, Vlahou A, Mischak H, Decramer S, Bascands JL, Schanstra JP.
Clinical proteomics in obstetrics and neonatology
Expert Rev Proteomics. 2014 Feb;11(1):75-89. Epub 2014 Jan 3.
253.
Suárez ER, Siwy J, Zürbig P, Mischak H.
Urine as a source for clinical proteome analysis: From discovery to clinical application
Biochim Biophys Acta. 2014, 1844(5):884-98. Epub 2013 Jul 2.
252.
Weissinger EM, Metzger J, Dobbelstein C, Wolff D, Schleuning M, Kuzmina Z, Greinix H, Dickinson AM, Mullen W, Kreipe H, Hamwi I, Morgan M, Krons A, Tchebotarenko I, Ihlenburg-Schwarz D, Dammann E, Collin M, Ehrlich S, Diedrich H, Stadler M, Eder M, Holler E, Mischak H, Krauter J, Ganser A.
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host-disease after allogeneic stem cell transplantation
Leukemia 2014, 28(4):842-52. Epub 2013 Jul 11.
251.
Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS.
Discovery and Validation of Urinary Biomarkers for Detection of Renal Cell Carcinoma
J Proteomics. 2014, 98:44-58. Epub 2013 Dec 25.
250.
Klein J, Papadopoulos T, Mischak H, Mullen W.
Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine
Electrophoresis 2014, 35(7):1060-4. Epub 2013 Nov 20.
249.
Duranton F, Lundin U, Gayrard N, Mischak H, Aparicio M, Mourad G, Daurès JP, Weinberger KM, Argilés A.
Plasma and Urinary Amino Acid Metabolomic Profiling in Patients with Different Levels of Kidney Function
Clin J Am Soc Nephrol 2014, 9(1):37-45. Epub 2013 Nov 14.